Myriad Genetics Overview
Myriad Genetics Target Price
Analysts' 12-month price predictions for MYGN.
Share Price
$4.03
Average Target Price
$12.00
197.8% upside
197.8% upside2 analysts in the last 4 months
High: $12.5 | Low: $11.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-12 | Piper Sandler | $12.5 | 210.2% upside |  |
| 2025-03-04 | Piper Sandler | $11.5 | 185.4% upside | |
| 2024-12-09 | Leerink PartnersPuneet Souda | $21 | 421.1% upside | |
| 2024-10-14 | ScotiabankSung Ji Nam | $34 | 743.7% upside | |
| 2024-09-19 | Morgan StanleyTejas Savant | $32 | 694% upside | |
| 2024-08-27 | Wells FargoBrandon Couillard | $35 | 768.5% upside | |
| 2024-08-07 | GuggenheimSubbu Nambi | $29 | 619.6% upside | |
| 2024-06-26 | ScotiabankSung Ji Nam | $29 | 619.6% upside | |
| 2024-05-13 | Piper SandlerJon Peterson | $28 | 594.8% upside | |
| 2023-12-21 | Piper SandlerDavid Westenberg | $23 | 470.7% upside | |
| 2022-10-05 | StephensMason Carrico | $22 | 445.9% upside | |
| 2022-04-19 | Goldman Sachs | $23 | 470.7% upside | |